PrimeX News

Broker News

First Light News: Peace Hopes Underpin Risk Rally
Tue, 16 Jun 2026 08:05:43 GMT
Natural Gas and Oil Forecast: Truce Stability Fuels Technical Recovery — What’s Next for Oil & NatGas?
Tue, 16 Jun 2026 07:44:30 GMT
Oil Price Forecast: WTI Tests $80 as Brent Falls on US-Iran Deal
Tue, 16 Jun 2026 03:56:00 GMT
U.S-Iran Peace Deal Ignites Gold’s Comeback Trade – Are You Positioned?
Mon, 15 Jun 2026 21:06:20 GMT
D-Wave Quantum (QBTS) Price Forecast: Bullish Retest Strengthens Setup
Mon, 15 Jun 2026 21:01:54 GMT
Silver (XAG/USD) Price Forecast: 200-Day Reclaim Targets Trend Recovery
Mon, 15 Jun 2026 20:52:20 GMT

ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Thu, 11 Jun 2026 17:22:12 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT

What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Mon, 15 Jun 2026 22:36:03 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT
How Renko Charts Filter Market Noise & Improve Trend Analysis
Sun, 10 May 2026 14:02:44 GMT
Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT

Advertisement

Advertisement

BMEA

Biomea Fusion, Inc. Common Stock

1.20

USD

+0.03

+2.56%

Jun 15, 16:00 UTC -4

Closed

exchange

Pre-Market

1.20

0.00

0.00%

BMEA News & Forecasts

featured

Biomea Fusion, Inc. (BMEA) Discusses Developments in Diabetes With Emphasis on Icovamenib and Clinical Trial Insights Transcript

featured

Biomea Fusion, Inc. (BMEA) Discusses Top Line Results From COVALENT-112 Trial of Icovamenib in Type 1 Diabetes Transcript

featured

Biomea Fusion, Inc. (BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes Transcript

featured

Biomea Fusion, Inc. (BMEA) Discusses Phase I Data and Clinical Potential of Oral GLP-1 Receptor Antagonist for Obesity Transcript

Advertisement

Advertisement

Advertisement